Rubin DT - Search Results

1

Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease.

Ollech JE, Normatov I, Peleg N, Wang J, Patel SA, Rai V, Yi Y, Singer J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Ollech JE, et al. Among authors: rubin dt. Clin Gastroenterol Hepatol. 2021 Jan;19(1):104-110. doi: 10.1016/j.cgh.2020.02.035. Epub 2020 Feb 26. Clin Gastroenterol Hepatol. 2021. PMID: 32109634 Free PMC article.

2

Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?

Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Rubin DT, et al. Gastrointest Endosc. 2007 Jun;65(7):998-1004. doi: 10.1016/j.gie.2006.09.025. Epub 2007 Apr 23. Gastrointest Endosc. 2007. PMID: 17451704

3

Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.

Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT. Pekow JR, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2010 Aug;16(8):1352-6. doi: 10.1002/ibd.21184. Inflamm Bowel Dis. 2010. PMID: 20027656 Free PMC article.

4

Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.

Cohen RD, Lewis JR, Turner H, Harrell LE, Hanauer SB, Rubin DT. Cohen RD, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2012 Jan;18(1):10-6. doi: 10.1002/ibd.21707. Epub 2011 Mar 31. Inflamm Bowel Dis. 2012. PMID: 21456032 Clinical Trial.

5

miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.

Pekow JR, Dougherty U, Mustafi R, Zhu H, Kocherginsky M, Rubin DT, Hanauer SB, Hart J, Chang EB, Fichera A, Joseph LJ, Bissonnette M. Pekow JR, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2012 Jan;18(1):94-100. doi: 10.1002/ibd.21742. Epub 2011 May 6. Inflamm Bowel Dis. 2012. PMID: 21557394 Free PMC article.

6

Assessment of variables associated with smoking cessation in Crohn's disease.

Leung Y, Kaplan GG, Rioux KP, Hubbard J, Kamhawi S, Stasiak L, Cohen RD, Devlin SM, Panaccione R, Hanauer SB, Rubin DT. Leung Y, et al. Among authors: rubin dt. Dig Dis Sci. 2012 Apr;57(4):1026-32. doi: 10.1007/s10620-012-2038-2. Epub 2012 Feb 7. Dig Dis Sci. 2012. PMID: 22311366

7

Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.

Hoentjen F, Hanauer SB, Hart J, Rubin DT. Hoentjen F, et al. Among authors: rubin dt. J Clin Gastroenterol. 2013 Jan;47(1):52-7. doi: 10.1097/MCG.0b013e3182582c1d. J Clin Gastroenterol. 2013. PMID: 22858512 Free PMC article.

8

Joseph Barnett Kirsner, MD, PhD.

Hanauer SB, Rubin DT. Hanauer SB, et al. Among authors: rubin dt. Clin Gastroenterol Hepatol. 2012 Nov;10(11):1181-2. doi: 10.1016/j.cgh.2012.09.021. Clin Gastroenterol Hepatol. 2012. PMID: 23084570 No abstract available.

9

Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.

Sakuraba A, Keyashian K, Correia C, Melek J, Cohen RD, Hanauer SB, Rubin DT. Sakuraba A, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2013 Mar;19(3):621-6. doi: 10.1097/MIB.0b013e31827eea78. Inflamm Bowel Dis. 2013. PMID: 23429449 Free PMC article.

10

Serum adalimumab concentration and clinical remission in patients with Crohn's disease.

Chiu YL, Rubin DT, Vermeire S, Louis E, Robinson AM, Lomax KG, Pollack PF, Paulson SK. Chiu YL, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2013 May;19(6):1112-22. doi: 10.1097/MIB.0b013e3182813242. Inflamm Bowel Dis. 2013. PMID: 23584130 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page